We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the funds benchmark index. The Biotech Index includes com... The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the funds benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified. Show more
VanEck announced today the following 2024 annual distributions per share for its VanEck® equity exchange-traded funds. Distributions Per Share for the VanEck ETFs Listed Below Ex-Date: December...
VanEck announced today the following 2023 annual distributions per share for its VanEck® equity exchange-traded funds. Distributions Per Share for the VanEck ETFs Listed Below Ex-Date: December...
IBOT offers global exposure to the rise of the robotics industry, which is projected to grow to over $90B by 2026.1 IBOT joins VanEck’s forward-looking thematic ETFs lineup, providing a way for...
VanEck announced today preliminary yearend distribution estimates for its VanEck Vectors® equity exchange-traded funds. Please note that these yearend estimates were made as of October...
ADVISORY, Sept. 12, 2016 (GLOBE NEWSWIRE) -- What:VanEck, a pioneer in global markets and experienced provider of innovative solutions, will visit the Nasdaq MarketSite in Times Square...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.68 | 0.430816016219 | 157.84 | 159.3214 | 155.41 | 18221 | 156.92849544 | SP |
4 | -8.48 | -5.07784431138 | 167 | 168.585 | 154.37 | 13324 | 159.41860489 | SP |
12 | -18.1 | -10.2479900351 | 176.62 | 178.9519 | 154.37 | 9152 | 163.51064715 | SP |
26 | -9.82 | -5.83343233931 | 168.34 | 183.6449 | 154.37 | 6925 | 169.00163441 | SP |
52 | -10.14 | -6.01209533974 | 168.66 | 183.6449 | 151.35 | 7374 | 166.69483693 | SP |
156 | -30.43 | -16.1047896269 | 188.95 | 188.95 | 131.115 | 12062 | 157.96577508 | SP |
260 | 21.28 | 15.5056834742 | 137.24 | 223.19 | 112.03 | 15458 | 163.28826922 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions